相关实验视频

Updated: Jan 16, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

CD137L通过HLTF调节促进黑色素瘤的免疫监测

Long Liang^1,2, Lin Zhu^1,3, Xin Li²

¹Department of Dermatology, Xiangya Hospital & School of Life Sciences, Central South University, Changsha, China.

Nature communications

|September 26, 2025

概括

在黑色素瘤细胞中增强CD137L表达增强了抗瘤免疫力和T细胞存活率. 这一发现支持与免疫检查点阻断剂 (ICB) 结合治疗,以改善癌症治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

免疫检查点阻断剂 (ICB) 在各种癌症中表现出有效性,但仅对一小部分患者有益.
确定新的治疗点对于提高ICB反应率至关重要.
使用ICB治疗黑色素瘤需要了解抵抗和反应的机制.

研究的目的:

确定新的治疗点,以提高ICB在黑色素瘤中的疗效.
阐明CD137L在抗瘤免疫和ICB反应中的作用.
探索涉及CD137L诱导和ICBs的组合策略.

主要方法:

整合了ICB治疗黑色素瘤患者的多omics数据.
在体外和体外功能测试以评估CD137L对抗瘤免疫力的影响.
机制研究以确定CD137L.的转录调节剂.
评估AICAR作为CD137L诱导的治疗剂.

主要成果:

在瘤CD137L表达和PD-1阻断疗效之间发现了正相关性.
在癌细胞中诱导CD137L增强了CD8+T细胞存活率和抗瘤免疫力.
酶样转录因子 (HLTF) 被确定为CD137L表达的关键调节者.
作为AMPK激活剂的AICAR诱导了CD137L,并与PD-1和CTLA-4阻断产生了协同作用.

结论:

CD137L在增强抗瘤免疫力和在黑色素瘤中的ICB疗效方面发挥着至关重要的作用.
通过HLTF介导的CD137L调节提供了对免疫反应调节的机制性洞察.
通过AICAR介导的CD137L诱导是一种有前途的组合疗法策略,可以改善黑色素瘤治疗结果.

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...